Compliance

The Peptide Website Compliance Checklist Processors Actually Use

Holistic Payments · Updated 2026-06-21 · 5 FAQs · Research-use-only and compliance focused

If your peptide brand keeps getting declined for card processing, or keeps getting shut off after a few good months, the problem usually is not your products. It is your website. Underwriters do not read your pitch deck. They open your storefront, click through it the way a customer would, and grade it against a fixed list of compliance signals. This is that list. Build to it, and you stop being the merchant a risk team flags on a Friday afternoon.

The reason this matters: a research-use-only (RUO) peptide site lives or dies on whether its presentation matches its legal posture. The moment a page implies human use, dosing, or a cure, the RUO shield collapses and the merchant becomes a regulatory and liability problem the processor will not carry. Below is what a reviewer checks, in roughly the order they check it, and how to pass each gate before you ever submit an application.

How underwriting actually reviews a peptide site

Underwriting is not a single yes or no. It is a sequence of risk checks, and a peptide brand triggers several at once: high chargeback potential, regulatory exposure under FDA and FTC rules, and an MCC that banks scrutinize. A reviewer is asking one question on every page: does this site present these products honestly as laboratory research materials, or is it quietly selling human therapy?

They look for two things. First, affirmative compliance signals that you put there on purpose: the age gate, the disclaimer, the labeling, the policies. Second, the absence of disqualifying signals: human-use language, dosing tables, before-and-after photos, medical imagery, testimonials about weight loss or healing. A clean site has all of the first and none of the second. For the wider context on how this fits a full application, see the RUO peptide payment processing guide.

The honest framing matters here. This checklist is not about hiding anything from your processor. It is the opposite. The whole argument for durable processing is that your public presentation genuinely matches a research-use-only business, so there is nothing to discover later. Cloaking content from a reviewer, or showing them a sanitized page while customers see something else, is the fastest way to lose your account and land on an industry blocklist.

1. A working age gate on entry

The first click. A reviewer expects an age verification interstitial before a visitor can browse products, confirming the buyer is 21 or older (some operators use 18, but 21 is the safer posture for this category). It should be unavoidable, not a dismissible banner, and it should set a state so the visitor is not asked again every page load.

What a reviewer wants to see:

The common failure is an ad bridge page or a deep link that skips the gate entirely. If your paid traffic lands straight on a product page with no age check, you have a hole. The deeper rationale and implementation patterns are covered in age gates and disclaimers as your RUO shield.

2. Prominent, consistent RUO disclaimers

A single line buried in the footer is not enough. Research-use-only language needs to appear where purchasing decisions happen: on the homepage, on every product page, in the cart, and at checkout. The wording should be plain and unhedged: "For laboratory research use only. Not for human consumption. Not a drug, food, or cosmetic."

Consistency is the tell. If the disclaimer says research-use-only but a product description says "supports recovery" or "for your protocol," the disclaimer is contradicted and a reviewer treats the contradiction as the truth. The disclaimer protects you only when nothing else on the page undermines it. For the labeling side of this, see the RUO labeling compliance breakdown.

3. No human-use claims, anywhere

This is the single most disqualifying item, and it is where most peptide sites fail. The instant a page tells a person what a compound will do for their body, the product is being marketed as an unapproved drug, and the RUO designation becomes a fiction. Reviewers scan product copy, blog posts, FAQ entries, meta descriptions, and image alt text for it.

Disqualifying language includes:

Note that the blog is where this most often leaks. A "human-use" lifestyle article quietly kills the research posture of the entire storefront. Keep editorial content strictly educational and research-framed, and never connect a compound to a personal outcome. The marketing-side risk is detailed in FTC and FDA risk in peptide marketing, and the broader failure pattern in why peptide payments get shut off.

4. No dosing, protocols, or reconstitution-for-use guidance

Dosing instructions are human-use claims in disguise. A milligram-per-day table, a reconstitution calculator framed around a personal regimen, a "suggested cycle," or a "stack" guide all signal that the product is meant to enter a human body. Reviewers treat dosing content as proof of intended human use regardless of any disclaimer elsewhere.

You can publish the genuine specifications of a research material: purity, molecular weight, storage conditions, handling notes for laboratory settings. What you cannot do is tell anyone how much to take, how often, or in what sequence. The line is the difference between describing a compound and prescribing it.

5. Lab-only product labeling and imagery

A reviewer will look at your product photos. Vials should be labeled as research materials, with the brand name and a clear research-use-only marking, and nothing that mimics a consumer drug or supplement: no dosage on the label, no human-benefit wording, no prescription-style packaging. Product names should stay generic to the category and avoid naming specific prescription compounds.

What to remove from imagery:

Clean imagery is a laboratory aesthetic: the vial, the lab, the data. The peptide labeling compliance guide goes deeper on what belongs on the physical vial and the digital product page.

6. Clear refund, shipping, and terms policies

This is a chargeback and consumer-protection check, and it is easy to pass, which is exactly why an empty policy page stands out. Card networks expect a merchant to publish accessible terms, a refund and return policy, a shipping policy with realistic timelines, and clear contact information including a business name and a working support channel.

For a high-chargeback category, transparent policies are a direct defense. They give you grounds to contest disputes and they reduce the friendly-fraud rate by setting expectations before the sale. Vague or missing policies read as a fly-by-night operation, which is precisely the profile a risk team declines. For how this connects to dispute defense, see chargeback management for peptides.

7. Honest checkout and accurate MCC

What the customer sees at checkout should match what they get, and the billing descriptor should be recognizable so buyers do not dispute a charge they do not recognize. Just as important: the business must be classified under an accurate merchant category code. Miscoding your MCC to slip past a risk filter is fraud against the processor and a fast path to termination and blocklisting.

The correct posture is to use the proper code for what you sell and then satisfy the underwriting that comes with it. That is the entire premise of compliant high-risk processing. The mechanics are laid out in MCC codes for research chemicals, and the platform-level fit in Stripe's research peptide policy.

8. Verifiable business identity and KYC readiness

Underwriting verifies the entity behind the site. Your legal business name, registration, and ownership should be consistent across your domain registration, your policies, your payment application, and your banking. Mismatches, privacy-shielded registrations with no corporate footprint, or a recently registered domain with no identifiable operator all raise the risk score.

Being KYC-ready means having your formation documents, beneficial-ownership details, and bank information assembled before you apply, so verification is fast rather than a back-and-forth that stalls the file. The full picture is in KYC and underwriting for peptide brands.

Quick pre-submission checklist

Before you apply, walk your own site as a stranger and confirm:

If all eight pass, you are presenting the profile underwriting approves, and just as important, the profile that survives a review six months from now.

FAQ

What is the fastest way to get my peptide site declined?

A human-use claim. One product description or blog post that tells a person what a compound does for their body undermines the research-use-only posture of the entire site, and a reviewer will treat that single line as the truth about your business.

Only if nothing on the page contradicts it. A disclaimer is necessary but not sufficient. If your copy implies human use, dosing, or benefits, the disclaimer is overridden by the rest of the page. Disclaimers protect a site that is already clean, not one that is selling therapy in everything but the fine print.

Can I keep a wellness blog if I sell research peptides?

You can publish educational, research-framed content, but the blog is the most common place compliance leaks. Avoid connecting any compound to a personal outcome, avoid dosing and protocols, and avoid second-person benefit language. Treat blog copy with the same scrutiny as a product page.

Will fixing my site stop my account from being frozen later?

A compliant site removes the most common triggers for sudden review and shut-off, but stability also depends on chargeback rates, accurate classification, and how your processor underwrites the category. The goal is a presentation built to survive scrutiny, not a guarantee. See frozen payments and what to do if you are already affected.

My current processor approved a non-compliant site. Am I safe?

A quiet approval is not durable approval. Sites that slip through a thin onboarding check are the ones shut off later when a deeper review or a chargeback spike pulls the file. The compliant path is more durable than the lucky one. If you need to move, migrating payment processors covers doing it without a gap.

Get approved with a site built to survive scrutiny

Holistic Payments underwrites research-use-only peptide brands the compliant way, on a Stripe Connect platform with four years of operating history, with access to peptide-friendly banking and deep RUO compliance expertise. We will review your site against this exact checklist before you go live, so you launch with a presentation that holds up to scrutiny rather than one that slips through and gets pulled later. Transparent, fair rolling reserves. Fast, low-friction onboarding because Stripe handles KYC. Rapid migration if you are leaving a processor that already shut you off.

If your site passes this checklist, you are the merchant we want. If it does not yet, we will tell you what to fix. Apply at holisticpayments.io and get processing that is built to last.

Need a payment rail built to survive scrutiny?

Holistic Payments does compliance-first card and ACH processing for RUO peptide and telehealth brands. Get approved and stay live.

Apply now